Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
May 27, 2020 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies Virtual...
Antares Pharma Reports First Quarter 2020 Operating and Financial Results
May 05, 2020 07:00 ET
|
Antares Pharma, Inc.
First Quarter 2020 Revenue $33.1 Million, a 42% Increase Compared to First Quarter 2019 Generated $5.6 Million in Cash from Operations during the First Quarter 2020 EWING, N.J., May 05, 2020 ...
Antares Pharma to Report First Quarter 2020 Operating and Financial Results
April 28, 2020 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., April 28, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first quarter 2020 financial results and recent operating progress before the...
Antares Pharma Reports Fourth Quarter and Full Year 2019 Operating and Financial Results
March 03, 2020 07:00 ET
|
Antares Pharma, Inc.
Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03 Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual Revenue EWING, N.J., March 03, 2020 (GLOBE...
Antares Pharma to Present at the Cowen and Company 40th Annual Health Care Conference
February 26, 2020 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company...
Antares Pharma to Report Fourth Quarter and Full Year 2019 Financial and Operating Results
February 25, 2020 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2019 financial results and recent operating...
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million
January 27, 2020 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (The Company) today announced 2020 full-year net revenue guidance of $135 to $155 million, which includes a range...
Antares Pharma Appoints Edward Tykot Senior Vice President, Corporate Development
December 10, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Edward Tykot to the position of Senior Vice President, Corporate Development....
Antares Pharma Social Media Campaign for XYOSTED® Wins MarCom Platinum Award
December 06, 2019 07:00 ET
|
Antares Pharma, Inc.
EWING, N.J., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”) today announced that the Company’s social media campaign for XYOSTED®, has been honored...
Antares Pharma to Present at the 31st Annual Piper Jaffray Healthcare Conference
November 27, 2019 17:51 ET
|
Antares Pharma, Inc.
EWING, N.J., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the 31st Annual Piper...